AN

Aspen Neuroscience

Source d’offres vérifiée

Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders

La Jolla, CA

Biotechnology Research
51 à 200 personnes

À propos

Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for Parkinson’s disease (PD) and extending across the brain and affected organs.

Postes ouverts

Sr. Clinical Specialist, Surgical Operations (Mountain West)

Sur place · Quinte West

Lead field-based clinical and technical support for neurosurgical Parkinson's cell therapy studies, ensuring site readiness and procedural execution. Translate field insights into scalable standards and operational strategies to improve surgical delivery across the clinical network.